Paper39456239
Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions.
Maqueda JJ and 2 others. Biomolecules, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions. Papers, record 39456239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39456239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Sarcoma | Major topic |
| Humans | |
| Child | |
| Liquid Biopsy | |
| Prognosis | |
| Rhabdomyosarcoma | |
| Sarcoma, Ewing | |
| Osteosarcoma | |
| Bone Neoplasms |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. 956285 (VAGABOND) | MSCA - EU Horizon 2020 research and innovation programme | PubMed | ||
| Ricerca Corrente | Italian Ministry of Health | PubMed |
Source PubMed
References145
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36652664 | Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma. | JCO Precis Oncol | 2023 | https://conductscience.org/library/papers/36652664 | PubMed |
| 2 | 23665678 | TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma. | Oncogene | 2014 | https://conductscience.org/library/papers/23665678 | PubMed |
| 3 | 20103643 | EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo. | Cancer Res | 2010 | https://conductscience.org/library/papers/20103643 | PubMed |
| 4 | 36044434 | Stability of circulating microRNAs in serum. | PLoS One | 2022 | https://conductscience.org/library/papers/36044434 | PubMed |
| 5 | 20637263 | Serum microRNAs as powerful cancer biomarkers. | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/20637263 | PubMed |
| 6 | 8722221 | Detection of tyrosinase mRNA from the blood of melanoma patients. | Cancer Epidemiol Biomarkers Prev | 1996 | https://conductscience.org/library/papers/8722221 | PubMed |
| 7 | 30123735 | Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy. | J Bone Oncol | 2018 | https://conductscience.org/library/papers/30123735 | PubMed |
| 8 | 24448245 | Universal marker and detection tool for human sarcoma circulating tumor cells. | Cancer Res | 2014 | https://conductscience.org/library/papers/24448245 | PubMed |
| 9 | 36211364 | Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36211364 | PubMed |
| 10 | 26050619 | The biology of circulating tumor cells. | Oncogene | 2016 | https://conductscience.org/library/papers/26050619 | PubMed |
| 11 | 29386915 | Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patients. | Cancer Manag Res | 2018 | https://conductscience.org/library/papers/29386915 | PubMed |
| 12 | 36551600 | The Role of Cell-Free DNA in Cancer Treatment Decision Making. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36551600 | PubMed |
| 13 | 31578374 | The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486. | Sci Rep | 2019 | https://conductscience.org/library/papers/31578374 | PubMed |
| 14 | 35303879 | Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. | Mol Cancer | 2022 | https://conductscience.org/library/papers/35303879 | PubMed |
| 15 | 35117548 | Strategies for enrichment of circulating tumor cells. | Transl Cancer Res | 2020 | https://conductscience.org/library/papers/35117548 | PubMed |
| 16 | 26349418 | Pediatric Rhabdomyosarcoma. | Crit Rev Oncog | 2015 | https://conductscience.org/library/papers/26349418 | PubMed |
| 17 | 34050156 | Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden. | Nat Commun | 2021 | https://conductscience.org/library/papers/34050156 | PubMed |
| 18 | 29759550 | Sarcoma-The standard-bearer in cancer discovery. | Crit Rev Oncol Hematol | 2018 | https://conductscience.org/library/papers/29759550 | PubMed |
| 19 | 32010687 | IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives. | Front Cell Dev Biol | 2019 | https://conductscience.org/library/papers/32010687 | PubMed |
| 20 | 32359482 | Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living. | Trends Mol Med | 2020 | https://conductscience.org/library/papers/32359482 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42220429 | Circulating Tumor DNA and microRNA-Based Liquid Biopsy for Longitudinal Treatment Monitoring and Recurrence Prediction in Pediatric Sarcomas: A Prospective Cohort Study. | Oncol Res | 2026 | https://conductscience.org/library/papers/42220429 | PubMed |
| 42022572 | Integrative biomarker and drug target discovery in osteosarcoma: traditional experimental approaches and AI-enabled insights. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42022572 | PubMed |
| 41987302 | A conceptual blueprint for "turning cold to hot" in Osteosarcoma: from TME stratification hypotheses to adaptive therapeutic prospects. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41987302 | PubMed |
| 41816119 | From imaging to omics: deep learning is bridging MRI and liquid biopsy in bone tumor diagnosis. | J Bone Oncol | 2026 | https://conductscience.org/library/papers/41816119 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39456239
GET https://conductscience.org/api/papers/v1/39456239/references?page=2